Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by qwerty22on Sep 27, 2022 1:50pm
107 Views
Post# 34989948

RE:RE:RE:RE:RE:57,000 views, THTX YouTube video link below

RE:RE:RE:RE:RE:57,000 views, THTX YouTube video link below

I mean there are potential negatives here. If you are a serious investor going to engage with the company at Cantor is what just happened a positive or negative (or irrelevant)? Does it dampen interest from those people if they know there's a whole bunch of new speculators with "don't forget to sell" as their mantra?

Would YOU buy into this speculative behaviour and hold beyond it?

It seems almost certainly set up to be a mini bubble that eventually burstS. That seems like the DNA of this event. Nobody probably has any ability to alter that trajectory., including thtx management. In a months time we'll be back to arguing about why they didn't take advantage of this opportunity when there's really probably nothing they can do.

I want the stock to consolidate at 2.50 and move higher on news. It would be great for this to be something meaningful. It's certainly more exciting than business as usual. I can't help think this is something tangential to what I'm invested in though.

Hopefully I'm wrong, mostly I am.


PWIB123 wrote: Not sure who you're addressing, but if you have any doubts, just go to Stocktwits and read the initial conversations after the link to ZipTrader was posted.  Thankfully, some of you have been answering questions and providing more information on THTX and the new speculators are engaging in ways other than the IV Push approval date.  There is no way the ZipTrader guy is affiliated with THTX leadership in any way shape or form, but it happened, so let's take advantage of having a larger audience.  
 

Biobob wrote: Speculation again, what do you know about what's going on...  nobody ever cared about Trogarzo after 2018....maybe it's a partnership deal coming up, a good news about th1902... maybe this turd from youtube has nothing to do with this....




<< Previous
Bullboard Posts
Next >>